Skip to Content


In the US, Zanamivir (zanamivir systemic) is a member of the following drug classes: inhaled anti-infectives, neuraminidase inhibitors and is used to treat Influenza, Influenza Prophylaxis and Swine Flu.

US matches:



ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Categories

Antiviral agent

Neuraminidase inhibitor

Treatment of influenza

Chemical Name

D-glycero-D-galacto-Non-2-enonic acid, 5-(acetylamino)-4-[(aminoiminoetyl)amino]-2,6-anhydro-3,4,5-trideoxy-

Foreign Names

  • Zanamivirum (Latin)
  • Zanamivir (German)
  • Zanamivir (French)
  • Zanamivir (Spanish)

Generic Names

  • Zanamivir (OS: BAN, USAN, DCF)
  • GG 167 (IS: GlaxoWellcome)
  • GR 121167 X (IS: GlaxoWellcome)
  • Zanamivir (PH: USP 38)

Brand Names

  • Relenza
    Glaxo Smithkline, Lebanon; Glaxo Wellcome, Bulgaria; Glaxo Wellcome, Malta; Glaxo Wellcome, Portugal; Glaxo Wellcome, Serbia; GlaxoSmithKline, Argentina; GlaxoSmithKline, Australia; GlaxoSmithKline, Canada; GlaxoSmithKline, Switzerland; GlaxoSmithKline, Chile; GlaxoSmithKline, China; GlaxoSmithKline, Czech Republic; GlaxoSmithKline, Denmark; GlaxoSmithKline, Ecuador; GlaxoSmithKline, Estonia; GlaxoSmithKline, Spain; GlaxoSmithKline, Finland; GlaxoSmithKline, Greece; GlaxoSmithKline, Hong Kong; GlaxoSmithKline, Croatia (Hrvatska); GlaxoSmithKline, Hungary; GlaxoSmithKline, Ireland; GlaxoSmithKline, Israel; GlaxoSmithKline, Iceland; GlaxoSmithKline, Italy; GlaxoSmithKline, Japan; GlaxoSmithKline, Lithuania; GlaxoSmithKline, Latvia; GlaxoSmithKline, Myanmar; GlaxoSmithKline, Netherlands; GlaxoSmithKline, Norway; GlaxoSmithKline, New Zealand; GlaxoSmithKline, Oman; GlaxoSmithKline, Philippines; GlaxoSmithKline, Poland; GlaxoSmithKline, Romania; GlaxoSmithKline, Serbia; GlaxoSmithKline, Sweden; GlaxoSmithKline, Singapore; GlaxoSmithKline, Slovenia; GlaxoSmithKline, Slovakia; GlaxoSmithKline, Thailand; GlaxoSmithKline, Tunisia; GlaxoSmithKline, Taiwan; GlaxoSmithKline, United States; GlaxoSmithKline, South Africa; GlaxoSmithKline Laboratoire Pharmaceutique, France; GlaxoSmithKline Pharma, Austria; GlaxoSmithKline UK, United Kingdom; GSK, Turkey; Wellcome Limited, Bosnia & Herzegowina; GlaxoSmithKline, Germany
  • Zanamivir - Simcere Pharm
    Simcere, China
  • Z-Flu
    Hetero, India


BANBritish Approved Name
DCFDénomination Commune Française
ISInofficial Synonym
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.